ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

ferric carboxymaltose

Also written as “Ferric Carboxymaltose (FCM)”, “Ferric carboxymaltose” and “Injectafer”.

Its studies are mostly in Anemia, Iron-Deficiency · Anemia · Iron Deficiencies · Restless Legs Syndrome · Heart Failure, led by 4 companies.

Drug pageFerric carboxymaltose: every studyAll 158 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Sep 23, 201346 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Daiichi Sankyo280 open or runningphase 4since Sep 23, 2013Apr 20, 2006none ahead
CSLits history only140 open or runningphase 4since Mar 29, 2010Aug 24, 2007none ahead
Sichuan Huiyu Pharmaceuticalits history only31 open or runningphase 1since Sep 27, 2023Sep 27, 2023none ahead
Novartisits history only10 open or runningphase 1since Dec 5, 2017Dec 5, 2017none ahead

Also a collaborator on its studies: Suzhou Guochen Biotechnology, Boji Medical Technology, ClinStar, Cytel, Tigermed Consulting, Pierrel Research Europe, ICON Clinical Research, Parexel and SGS.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Daiichi Sankyo only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 14 studies since Apr 20, 2006.

  1. Oct 4, 2010Phase 2 study in Anemia, Iron-DeficiencyNCT01307007 · 69 enrolled
  2. Nov 10, 2010Phase 2 study in Anemia, Iron-DeficiencyNCT01290315 · 49 enrolled · United States
  3. Feb 23, 2011Phase 2 study in Restless Legs SyndromeNCT01382901 · 45 enrolled
  4. Sep 23, 2013Phase 4 study in Anemia, Iron-DeficiencyNCT01950247 · 1,025 enrolled
  5. Mar 12, 2014Phase 4 study in Iron Deficiency Anemia Secondary to IBD or Gastric BypassNCT02086968 · 198 enrolled
  6. Mar 18, 2015Phase 3 study in Restless Legs SyndromeNCT02397057 · 209 enrolled · United States
  7. Mar 27, 2015Phase 2 study in Anemia, Iron-DeficiencyNCT02410213 · 35 enrolled · Poland, Russian Federation
  8. Apr 1, 2015Phase 2 study in Iron DeficienciesNCT02409459 · 81 enrolled · United States
  9. May 21, 2015Phase 3 study in NeoplasmsNCT02453334 · 244 enrolled · United States
  10. Jun 30, 2016Phase 2 study in Restless Legs SyndromeNCT02826681 · 70 enrolled · United States
  11. Jan 25, 2017Phase 3 study in Heart FailureNCT03037931 · 3,065 enrolled · United States, Australia, Bulgaria and more
  12. Apr 17, 2018Phase 3 study in Anemia, Iron-DeficiencyNCT03523117 · 79 enrolled · United States
  13. Feb 12, 2020Phase 3 study in Anemia, Iron-DeficiencyNCT04269707 · 7 enrolled · United States
  14. Nov 2, 2020Phase 2 study in Anemia, Iron-DeficiencyNCT04968379 · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 28 Daiichi Sankyo leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT04968379Anemia, Iron-Deficiency · United States2WithdrawnOct 8, 20240
NCT04269707Anemia, Iron-Deficiency · United States3CompletedDec 30, 20207
NCT03523117Anemia, Iron-Deficiency · United States3CompletedDec 22, 202079
NCT03037931Heart Failure · United States, Australia, Bulgaria and more3CompletedFeb 2, 20233,065
NCT02826681Restless Legs Syndrome · United States2TerminatedSep 4, 202170
NCT02453334Neoplasms · United States3CompletedJan 2018244
NCT02409459Iron Deficiencies · United States2CompletedOct 201581
NCT02410213Anemia, Iron-Deficiency · Poland, Russian Federation2CompletedJan 22, 201735
NCT02397057Restless Legs Syndrome · United States3CompletedJan 2018209
NCT02086968Iron Deficiency Anemia Secondary to IBD or Gastric Bypass4CompletedJul 16, 2016198
NCT01950247Anemia, Iron-Deficiency4CompletedMay 20, 20151,025
NCT01382901Restless Legs Syndrome2CompletedJul 200745
NCT01290315Anemia, Iron-Deficiency · United States2CompletedMar 201349
NCT01307007Anemia, Iron-Deficiency2CompletedMay 201169
NCT00982007Anemia, Iron-Deficiency · United States3CompletedMar 2011997
NCT00981045Anemia, Iron-Deficiency · United States3CompletedJul 20112,561
NCT00740246Anemia · United States3CompletedFeb 2006594
NCT00704353Anemia · United States3CompletedJul 2009735
NCT00704028Anemia · United States3CompletedJan 2010161
NCT00703937Anemia · United States3CompletedJul 2009708
NCT00685815Restless Legs Syndrome · United States2CompletedDec 201012
NCT00548860Anemia · United States3CompletedMar 20092,018
NCT00548691Anemia · United States3CompletedJan 2009513
NCT00396292Anemia · United States3CompletedNov 2005361
NCT00395993Anemia · United States3CompletedApr 2006456
NCT00354484Anemia · United States3CompletedDec 2006291
NCT00317239Anemia · United States3CompletedFeb 2007255
NCT00317226Anemia · United States3CompletedMar 2007145

How it is read

Names in the registry

  • “Ferric Carboxymaltose (FCM)”, 13 entries
  • “Ferric carboxymaltose”, 8 entries
  • “Injectafer”, 5 entries
  • “Ferric Carboxymaltose”, 5 entries
  • “Ferric Carboxymaltose Injection”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.